Contact Us


Want more information? Let us know what you need and we will get back to you. We look forward to hearing from you!

    Verity Solutions

    12131 113th Ave NE
    Suite 200
    Kirkland, WA 98034

    Support

    800.581.1378

    Sales

    425.947.1922


    Would you like to submit a proposal for us to bid on?

    Send to proposals@verity340b.com

    X

    News

    Blog articles that provide information about our solutions, services, and other 340B program insights.

    Action on 340B Contract Pharmacies Turns to the States

    Action on 340B Contract Pharmacies Turns to the States By Ted Slafsky As we approach the 16-month mark since we had pivotal arguments over the 340B contract pharmacy program in two federal appellate courts and Congress continues to offer no relief, a growing number of 340B providers are turning to state legislatures for help.  In […]

    View Article   

    Hospitals Are Not the Only 340B Providers Under Scrutiny

    Hospitals Are Not the Only 340B Providers Under Scrutiny By Ted Slafsky Veteran 340B observers were surprised to see that Sen. Bill Cassidy (R-La.) has expanded his 340B investigation into community health centers. In September, Cassidy, a long-time critic of the program, launched an inquiry into hospital use of the 340B program. Cassidy cited front-page […]

    View Article   

    Why the Genesis 340B Patient Definition Court Decision Could Resolve the Contract Pharmacy Impasse

    Why the Genesis 340B Patient Definition Court Decision Could Resolve the Contract Pharmacy Impasse By Ted Slafsky In what legal experts describe as a landmark decision, the U.S. District Court for the District of South Carolina ruled Nov. 3 that the plain wording of the 340B statute does not require a covered entity to have […]

    View Article   

    Whether it is 340B Policy or Keeping the Lights On, House Chaos Underscores Senate’s Importance

    Whether it is 340B Policy or Keeping the Lights On, House Chaos Underscores Senate’s Importance By Ted Slafsky According to our history lessons, George Washington told Thomas Jefferson that the Senate was created to serve as a saucer to “cool” the House’s hot cup of tea. There is still debate about whether this conversation ever […]

    View Article   

    Could the States Resolve the Contract Pharmacy Impasse?

    Could the States Resolve the Contract Pharmacy Impasse? By Ted Slafsky After a recent lull in the ongoing battle over whether drug manufacturers can continue to place restrictions on access to 340B discounts in the contract pharmacy setting, things are heating up at the state level. Recently, Louisiana and its bordering state to the north, […]

    View Article   

    The Big Question on the Minds of Every 340B Stakeholder

    The Big Question on the Minds of Every 340B Stakeholder By Ted Slafsky As we pass the third anniversary of the pharmaceutical industry’s surprise decision to significantly scale back access to 340B pricing in the contract pharmacy setting, the key question is:  Why is it taking so long to come up with a resolution?  One […]

    View Article   

    The Growing Inevitability of New 340B Reporting Requirements

    The Growing Inevitability of New 340B Reporting Requirements By Ted Slafsky Just before the end of most state legislative sessions for 2023, two states enacted the first ever 340B-specific reporting requirements for covered entities. As my colleague Will Newton reported in 340B Report, Minnesota was the first to enact a reporting law. It is a […]

    View Article   

    Lessons from Two State Legislatures and What They Mean for 340B Stakeholders

    Lessons from Two State Legislatures and What They Mean for 340B Stakeholders By Ted Slafsky As many 2023 state legislative sessions come to an end, it is a good time to take a closer look at two states—one in the South and one in the Northeast—to see how they are tackling some of the most […]

    View Article   

    Could We Have a Breakthrough in the Contract Pharmacy Battle?

    Could We Have a Breakthrough in the Contract Pharmacy Battle? By Ted Slafsky As we reach the third-year mark since pharmaceutical manufacturers began to restrict access to 340B pricing in the contract pharmacy setting, we recently experienced a watershed moment that I believe will lead to an end of the standoff between the government and […]

    View Article   

    A Cheat Sheet of the Growing List of 340B Groups

    A Cheat Sheet of the Growing List of 340B Groups By Ted Slafsky With the recent launch of 340B Truth and with several other advocacy/educational groups using 340B in their names, it is a good time to provide a tutorial on the different groups and their goals.  The list below is not exhaustive but reflects […]

    View Article